Gary J. Kelloff
Impact in
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
Papers in
-
- Cancer Genomics and Diagnostics 5
- Cancer, Lipids, and Metabolism 3
- Co-authors
- Ronald A. Lubet (8 shared papers)Vernon E. Steele (10 shared papers)Karen Seibert (2 shared papers)Russell F. Jacoby (1 shared paper)Carolyn E. Cole (1 shared paper)Bandaru S. Reddy (2 shared papers)Chinthalapally V. Rao (2 shared papers)Charles W. Boone (9 shared papers)
- Journals
- Journal of Cellular Biochemistry (13 papers)Carcinogenesis (2 papers)Journal of Nutrition (1 paper)Lung Cancer (1 paper)Advances in experimental medicine and biology (1 paper)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Gary J. Kelloff
32 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 99
- Pharmacology 689
- Cancer Research 356
- Pathology and Forensic Medicine 362
- Genetics 593
- Biochemistry 114
Countries citing papers authored by Gary J. Kelloff
This map shows the geographic impact of Gary J. Kelloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary J. Kelloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary J. Kelloff more than expected).
Fields of papers citing papers by Gary J. Kelloff
This network shows the impact of papers produced by Gary J. Kelloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary J. Kelloff. The network helps show where Gary J. Kelloff may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary J. Kelloff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. | 2000 | 413 |
| 2 | Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. | 2000 | 384 |
| 3 | Enhancement of experimental colon cancer by genistein. | 1997 | 153 |
| 4 | 1996 | 125 | |
| 5 | Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. | 1994 | 104 |
| 6 | Apoptosis, cell replication, and Western-style diet-induced tumorigenesis in mouse colon. | 1996 | 86 |
| 7 | 1996 | 85 | |
| 8 | Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives. | 1996 | 77 |
| 9 | 1995 | 74 | |
| 10 | Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid. | 1999 | 67 |
| 11 | Aromatase inhibitors as potential cancer chemopreventives. | 1998 | 58 |
| 12 | 1993 | 56 | |
| 13 | 1993 | 53 | |
| 14 | 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice. | 2001 | 44 |
| 15 | 1994 | 37 | |
| 16 | Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice. | 1999 | 35 |
| 17 | 1999 | 29 | |
| 18 | A quantitative angiogenesis model for efficacy testing of chemopreventive agents. | 2002 | 28 |
| 19 | 1993 | 27 | |
| 20 | 1995 | 25 |
About Gary J. Kelloff
Gary J. Kelloff is a scholar working on Molecular Biology, Cancer Research, Oncology, Genetics and Pathology and Forensic Medicine, having authored 32 papers that have together received 2.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (6 papers), Estrogen and related hormone effects (6 papers), Cancer Genomics and Diagnostics (5 papers), Genetic factors in colorectal cancer (5 papers), Cancer, Lipids, and Metabolism (3 papers), Colorectal Cancer Screening and Detection (3 papers), Nutrition, Genetics, and Disease (3 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Pharmacology (689 citations), Cancer Research (356 citations), Pathology and Forensic Medicine (362 citations), Genetics (593 citations) and Biochemistry (114 citations). Gary J. Kelloff has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Ronald A. Lubet, Vernon E. Steele, Karen Seibert, Russell F. Jacoby, Carolyn E. Cole, Bandaru S. Reddy, Chinthalapally V. Rao, Charles W. Boone, Caroline C. Sigman and James A. Crowell. Their work appears in journals such as Journal of Cellular Biochemistry, Carcinogenesis, Journal of Nutrition, Lung Cancer and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.